We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

215 hedge funds and large institutions have $482M invested in ARK Genomic Revolution ETF in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 56 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more call options, than puts

Call options by funds: $109M | Put options by funds: $96.5M

1.15% more ownership

Funds ownership: 52.03% → 53.18% (+1.1%)

4% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 56

10% less funds holding

Funds holding: 239 → 215 (-24)

16% less capital invested

Capital invested by funds: $575M → $482M (-$92.6M)

43% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 42

Holders
215
Holders Change
-24
Holders Change %
-10.04%
% of All Funds
2.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
54
Reduced
56
Closed
42
Calls
$109M
Puts
$96.5M
Net Calls
+$12.7M
Net Calls Change
-$6.93M

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$31.5M
2
Citigroup
Citigroup
New York
+$22.7M
3
JP Morgan Chase
JP Morgan Chase
New York
+$16.1M
4
Wells Fargo
Wells Fargo
California
+$14.7M
5
SG Americas Securities
SG Americas Securities
New York
+$2.82M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$39.6M
2
Morgan Stanley
Morgan Stanley
New York
-$28.1M
3
Two Sigma Investments
Two Sigma Investments
New York
-$22.6M
4
Goldman Sachs
Goldman Sachs
New York
-$8.47M
5
Jane Street
Jane Street
New York
-$7.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
201
Chesapeake Asset Management
New York
$522 – – –
BC
202
Barrett & Company
Rhode Island
$519 – – –
NWM
203
Nova Wealth Management
Florida
$519 – – –
WCM
204
WealthTrak Capital Management
Virginia
$519 – – –
NSG
205
Nalls Sherbakoff Group
Tennessee
$477 +$578 +23 New
MMCM
206
Murphy & Mullick Capital Management
New York
$415 – – –
WSFS
207
Wilmington Savings Fund Society
Delaware
$415 – – –
EWM
208
Evermay Wealth Management
Virginia
$312 – – –
GSWM
209
Golden State Wealth Management
California
$311 – – –
CFD
210
Creative Financial Designs
Indiana
$272 – – –
YAL
211
Your Advocates Ltd
Texas
$208 – – –
MSG
212
Main Street Group
Virginia
$125 – – –
FRA
213
Front Row Advisors
California
$104 – – –
HNB
214
Huntington National Bank
Ohio
$21 – – –
Qube Research & Technologies (QRT)
215
Qube Research & Technologies (QRT)
United Kingdom
$21 – – –
Two Sigma Investments
216
Two Sigma Investments
New York
– -$22.6M -961,500 Closed
KF
217
Krilogy Financial
Missouri
– -$2.76M -117,276 Closed
Citadel Advisors
218
Citadel Advisors
Florida
– -$1.99M -79,357 Closed
BSCCG
219
Blue Sky Capital Consultants Group
California
– -$1.51M -64,163 Closed
MA
220
Mutual Advisors
Nebraska
– -$931K -38,376 Closed
QC
221
Quadrature Capital
United Kingdom
– -$561K -23,826 Closed
Millennium Management
222
Millennium Management
New York
– -$519K -22,039 Closed
AWF
223
Alpha Wealth Funds
Utah
– -$471K -20,000 Closed
CAPTRUST Financial Advisors
224
CAPTRUST Financial Advisors
North Carolina
– -$399K -16,953 Closed
Group One Trading
225
Group One Trading
Illinois
– -$426K -16,949 Closed
7 8
9
10 11

ARKG Hedge Fund Activity: Q1 2025 in Review

215 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2025, worth a combined $482M — down 16% from $575M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ARKG and 24 opened new positions — a net loss of 18 holders — while 56 trimmed existing stakes and 54 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $31.5M. The largest seller was Bank of America, cutting an estimated $39.6M.

  • 215 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2025, down from 239 in Q4 2024.
  • Funds reported $482M of ARK Genomic Revolution ETF stock for Q1 2025, down 16% quarter-over-quarter.
  • 24 funds opened new ARK Genomic Revolution ETF positions in Q1 2025 and 42 closed out, a net change of -18 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2025 was BNP Paribas Financial Markets, an estimated $31.5M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2025 was Bank of America, an estimated $39.6M sold.

Based on aggregated 13F filings for Q1 2025.